PMC:3724992 / 21172-21516 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3724992","sourcedb":"PMC","sourceid":"3724992","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3724992","text":"In conclusion, our results suggest that neuritin13–21, neuritin121–129 and neuritin4–12 might be capable of inducing HLA-A2.1-restricted CD8+ CTL, which would be lethal for neuritin and HLA-A2.1 positive cells. Therefore, identification of neuritin peptide would contribute to the design of epitope-based vaccine for astrocytomas immunotherapy.","tracks":[]}